Pitfalls in the diagnosis of leprous neuropathy: Lessons learnt from a University hospital in an endemic zone

作者: Madhu Nagappa , Yasha T. Chickabasaviah , Anita Mahadevan , Raja Parthiban , Arun B. Taly

DOI: 10.1016/J.JNS.2015.07.046

关键词:

摘要: Leprosy is the oldest disease known to mankind and has piqued humans since Before Christian Era (BCE) [1]. The causative agent, Mycobacterium leprae, was thefirst bacterium be identified as causing in humans. Effective treatment, viz, Promin, introduced only 1940s. Multi-drug therapy came into vogue 1970s [2,3] popularised by World Health Organisation (WHO) 1980s. This resulted a rapid decline new case detection rates [4]. Global efforts eliminate leprosy have met with partial success continues prevail certain endemic pockets developing countries [5–8]. In India prevalence of reduced from 58 per 10,000 population 1980 0.69 2010 [9]. Thus, been ‘eliminated’ public health problem.However, this not ensured complete interruption transmission cases continue occur, sometimes after several years because long incubation period. underscores need for active continued identify primary targets M. leprae are skin peripheral nerves [6]. diagnosis rests on demonstration one or more three cardinal signs namely anaesthetic/hypoesthetic patches, thickened impaired sensation areas innervated affected acid-fast bacilli smear [4,10]. Characteristically, superficial cooler regions body [11,12]. commonly include ulnar, radial, median, lateral popliteal, tibial, facial trigeminal [13]. Leprous neuropathy can occur absence lesions [14]. Even presence lesions, mismatch severity vis-a-vis occurs. Thus may paucibacillary skin, but multibacillary [15,16]. Untreated delayed treatment major cause disability, deformity, morbidity social isolation patients [11]. it imperative recognise establish an early institute timely therapy. Meanwhile, each considered highly sensitive specific A considerable skill experience required detecting their failing which missed [17].

参考文章(88)
Chacko Cj, Fritschi Ep, Arunthathi S, Pannikar Vk, A clinico-pathological study of primary neuritic leprosy. Leprosy in India. ,vol. 55, pp. 212- ,(1983)
J.M.K. Murthy, Faram D. Dastur, Satish V. Khadilkar, Dhanpat K. Kochar, Rabies, tetanus, leprosy, and malaria. Handbook of Clinical Neurology. ,vol. 121, pp. 1501- 1520 ,(2014) , 10.1016/B978-0-7020-4088-7.00101-2
Bhatki Ws, Pandya Ss, Severe pan-sensory neuropathy in leprosy. International Journal of Leprosy and Other Mycobacterial Diseases. ,vol. 62, pp. 24- 31 ,(1994)
David M. Scollard, The biology of nerve injury in leprosy. Leprosy Review. ,vol. 79, pp. 242- 253 ,(2008) , 10.47276/LR.79.3.242
Hunegnaw M, Currie H, Hansen S, Duncan Me, Frommel D, Facial burning in women with leprosy, physiological or pathological? Ethiopian Medical Journal. ,vol. 45, pp. 35- 41 ,(2007)
Oztürk A, Koyuncu M, Saunders M, Celik O, Audiovestibular system, fifth and seventh cranial nerve involvement in leprosy. Indian journal of leprosy. ,vol. 66, pp. 421- 428 ,(1994)
Girdhar Bk, Husain S, Malaviya Gn, Mishra B, Mukherjee A, Girdhar A, Neuritic leprosy : Further progression and significance Acta leprologica. ,vol. 9, pp. 187- 194 ,(1995)
Vandana Pradhan, S. S. Badakere, U. Shankar Kumar, Increased incidence of cytoplasmic ANCA (cANCA) and other autoantibodies in leprosy patients from western India. Leprosy Review. ,vol. 75, pp. 50- 56 ,(2004) , 10.47276/LR.75.1.50
McDougall Ac, Languillon J, Yawalkar Sj, Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy. International Journal of Leprosy and Other Mycobacterial Diseases. ,vol. 47, pp. 37- 43 ,(1979)